News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
118,827 Results
Type
Article (4764)
Company Profile (43)
Press Release (114019)
Section
Business (41684)
Career Advice (123)
Deals (6961)
Drug Delivery (8)
Drug Development (13621)
Employer Resources (19)
FDA (2606)
Job Trends (3060)
News (63441)
Policy (4382)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (374)
Accelerated approval (4)
Adcomms (2)
Allergies (17)
Alliances (5865)
ALS (27)
Alzheimer's disease (371)
Antibody-drug conjugate (ADC) (58)
Approvals (2737)
Artificial intelligence (64)
Autoimmune disease (21)
Automation (5)
Bankruptcy (29)
Best Places to Work (2578)
BIOSECURE Act (2)
Biosimilars (27)
Biotechnology (29)
Bladder cancer (52)
Brain cancer (6)
Breast cancer (223)
Cancer (1048)
Cardiovascular disease (72)
Career advice (110)
Career pathing (1)
CAR-T (58)
CDC (4)
Cell therapy (130)
Cervical cancer (11)
Clinical research (12280)
Collaboration (214)
Compensation (101)
Complete response letters (4)
COVID-19 (465)
CRISPR (16)
C-suite (61)
Cystic fibrosis (40)
Data (1347)
Depression (19)
Diabetes (91)
Diagnostics (1230)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (26)
Drug pricing (22)
Drug shortages (1)
Duchenne muscular dystrophy (24)
Earnings (32364)
Editorial (3)
Employer branding (8)
Employer resources (18)
Events (14927)
Executive appointments (61)
FDA (3328)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (161)
Gene editing (25)
Generative AI (2)
Gene therapy (80)
GLP-1 (152)
Government (618)
Guidances (272)
Healthcare (3750)
HIV (10)
Huntington's disease (3)
IgA nephropathy (11)
Immunology and inflammation (33)
Immuno-oncology (9)
Indications (28)
Infectious disease (514)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (19)
Intellectual property (32)
Interviews (11)
IPO (4284)
IRA (2)
Job creations (571)
Job search strategy (107)
JPM (8)
Kidney cancer (8)
Labor market (17)
Layoffs (99)
Legal (712)
Liver cancer (25)
Longevity (1)
Lung cancer (106)
Lymphoma (104)
Machine learning (8)
Management (3)
Manufacturing (122)
MASH (21)
Medical device (2625)
Medtech (2635)
Mergers & acquisitions (2834)
Metabolic disorders (176)
Multiple sclerosis (42)
NASH (2)
Neurodegenerative disease (47)
Neuropsychiatric disorders (15)
Neuroscience (580)
NextGen: Class of 2026 (962)
Non-profit (933)
Now hiring (7)
Obesity (62)
Opinion (25)
Ovarian cancer (70)
Pain (32)
Pancreatic cancer (30)
Parkinson's disease (40)
Partnered (3)
Patents (56)
Patient recruitment (56)
Peanut (4)
People (4843)
Pharmaceutical (11)
Pharmacy benefit managers (4)
Phase 1 (2957)
Phase 2 (5117)
Phase 3 (5096)
Pipeline (1783)
Policy (20)
Postmarket research (506)
Preclinical (1041)
Press Release (11)
Prostate cancer (46)
Psychedelics (7)
Radiopharmaceuticals (35)
Rare diseases (154)
Real estate (800)
Recruiting (11)
Regulatory (3751)
Reports (11)
Research institute (362)
Resumes & cover letters (11)
Rett syndrome (3)
RNA editing (2)
RSV (14)
Schizophrenia (34)
Series A (28)
Series B (17)
Service/supplier (1)
Sickle cell disease (16)
Special edition (4)
Spinal muscular atrophy (21)
Sponsored (19)
Startups (382)
Stomach cancer (1)
Supply chain (13)
Tariffs (11)
Vaccines (201)
Venture capital (9)
Weight loss (36)
Women's health (9)
Date
Today (23)
Last 7 days (104)
Last 30 days (319)
Last 365 days (6060)
2026 (474)
2025 (6095)
2024 (6805)
2023 (7656)
2022 (10988)
2021 (13017)
2020 (10898)
2019 (7967)
2018 (6297)
2017 (5424)
2016 (4895)
2015 (6031)
2014 (3947)
2013 (2816)
2012 (3109)
2011 (3497)
2010 (3105)
Location
Africa (117)
Alabama (11)
Alaska (2)
Arizona (43)
Arkansas (1)
Asia (7124)
Australia (951)
California (1963)
Canada (612)
China (186)
Colorado (79)
Connecticut (111)
Delaware (85)
Europe (19122)
Florida (309)
Georgia (77)
Hawaii (1)
Idaho (16)
Illinois (157)
India (15)
Indiana (118)
Iowa (1)
Japan (157)
Kansas (20)
Kentucky (7)
Louisiana (11)
Maine (15)
Maryland (240)
Massachusetts (1388)
Michigan (53)
Minnesota (102)
Mississippi (1)
Missouri (22)
Montana (3)
Nebraska (3)
Nevada (33)
New Hampshire (11)
New Jersey (855)
New Mexico (3)
New York (535)
North Carolina (373)
North Dakota (6)
Northern California (991)
Ohio (62)
Pennsylvania (465)
Puerto Rico (10)
Rhode Island (6)
South America (156)
South Carolina (2)
Southern California (730)
Tennessee (22)
Texas (229)
United States (7506)
Utah (61)
Virginia (74)
Washington D.C. (8)
Washington State (162)
Wisconsin (17)
118,827 Results for "70".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IGC Pharma Reaches 70% Enrollment in Phase 2 CALMA Trial Evaluating IGC-AD1 for Alzheimer’s Agitation
February 2, 2026
·
3 min read
Press Releases
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
December 30, 2025
·
4 min read
Press Releases
ACS Annual Statistics Report: Milestone 70 Percent 5-Year Survival Rate for all Cancers Combined; Largest Gains for Advanced and Fatal Cancers
January 13, 2026
·
5 min read
Layoffs
Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset
Kezar Life Sciences suffered multiple clinical holds and four patient deaths in a trial testing zetomipzomib for lupus—a program that has since been canned. The company is still pursuing development in autoimmune hepatitis, but recent FDA communications could delay its timeline.
November 10, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
January 15, 2026
·
6 min read
Press Releases
Pharmaceutical CDMO Market Size Worth USD 368.70 Bn By 2034 Driven by Biologics and Advanced Therapies Demand
December 1, 2025
·
1 min read
Press Releases
U.S. Antibody Drug Conjugates Market Set to Reach USD 11.70 Billion by 2034
November 13, 2025
·
1 min read
Press Releases
Implantable Medical Devices Market Size to Surpass USD 179.70 Billion by 2034
October 17, 2025
·
1 min read
Press Releases
Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer
December 11, 2025
·
4 min read
Press Releases
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
October 22, 2025
·
8 min read
1 of 11,883
Next
